Source: International Congress 2016 – Novel strategies on COPD and asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Siva Mahendran (Watford, United Kingdom), Siva Mahendran, Rosemary Ebling, Mohammad Ibrahim, Tariq Sethi. LATE-BREAKING ABSTRACT: IgE immunadsorption in allergic bronchopulmonary aspergillosis: A pilot study. Eur Respir J 2016; 48: Suppl. 60, 4835

Member's Comments

No comment yet.

Related content which might interest you: Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Asthma Year: 2013 Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Allergic versus non allergic asthma: What makes the difference? Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 First clinical trial of a new IgE-adsorber in allergic asthma Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015 Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 LATE-BREAKING ABSTRACT: Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Treating allergic bronchopulmonary aspergillosis: the way forward Source: Eur Respir J 2016; 47: 385-387 Year: 2016 Omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA): a multicenter case series study in Spain Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Real-life experience of Omalizumab in adult Cystic Fibrosis patients with allergic severe asthma and Allergic Bronchopulmonary Aspergillosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 LATE-BREAKING ABSTRACT: Bronchial microbiome in severe persistent oral corticosteroid-dependent asthma Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 Burden of Allergic Bronchopulmonary Aspergillosis (ABPA) in the India bronchiectasis registry. Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Effect of vitamin d therapy on the pulmonary functions in pediatric asthma and allergic rhinitis Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015